Virtu KCG Holdings’s Enzo Biochem, Inc. ENZ Stock Holding History

Virtu KCG Holdings’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$224K	Buy	20,266 +3,466	+21%	+$32.3K	0.01%	2044
2017 Q1	$141K	Buy	+16,800	New	+$118K	﹤0.01%	2572
2016 Q4	–	Sell	-16,562	Closed	-$84K	–	3866
2016 Q3	$84K	Buy	+16,562	New	+$98.9K	﹤0.01%	2677
2016 Q1	–	Sell	-11,492	Closed	-$52K	–	3793
2015 Q4	$52K	Buy	+11,492	New	+$48.5K	﹤0.01%	3151
2015 Q3	–	Sell	-10,013	Closed	-$30K	–	3898
2015 Q2	$30K	Sell	10,013 -29,506	-75%	-$82.9K	﹤0.01%	3148
2015 Q1	$117K	Buy	+39,519	New	+$129K	﹤0.01%	2611
2014 Q3	–	Sell	-119,057	Closed	-$625K	–	4148
2014 Q2	$625K	Buy	119,057 +108,315	+1,008%	+$468K	0.01%	1701
2014 Q1	$45K	Buy	+10,742	New	+$36.8K	﹤0.01%	3351
2013 Q4	–	Sell	-10,707	Closed	-$27K	–	4338
2013 Q3	$27K	Buy	+10,707	New	+$25.4K	﹤0.01%	3590

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Virtu KCG Holdings's ENZ Position: Q2 2017 in Review

Virtu KCG Holdings increased its Enzo Biochem, Inc. (ENZ) stake by 21% in Q2 2017, buying an estimated $32.3K and bringing the position to 20,266 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #2044.

Virtu KCG Holdings first reported a position in ENZ in Q3 2013 and has held it in 9 quarters since. The position peaked at $625K in Q2 2014. 120 funds tracked by Wall St. Rank hold ENZ as of Q2 2017.

Virtu KCG Holdings held 20,266 shares of Enzo Biochem, Inc. worth $224K as of Q2 2017.
Virtu KCG Holdings bought 3,466 Enzo Biochem, Inc. shares in Q2 2017, an estimated $32.3K.
Enzo Biochem, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2044 holding.
Virtu KCG Holdings first reported a position in Enzo Biochem, Inc. in Q3 2013 and has held it in 9 quarters since.
Virtu KCG Holdings's Enzo Biochem, Inc. position peaked at $625K in Q2 2014.
120 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.